FDA Inspection
ENDO USA, IncENDO USA, Inc – FDA Inspection, Dec 7, 2012
Record Details
This FDA Inspection record concerns ENDO USA, Inc, with an inspection on December 7, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- ENDO USA, Inc
- Inspection Date
- December 7, 2012
- Product Type
- Drugs
View Company Profile
ID · 126d1455-2263-4d2c-b5bb-8d11fbf99f53
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 809209
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.42(c)(7)Quarantined Drug Products Area
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ENDO USA, Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2025 | Not classified | New York District Office | |
| March 3, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for ENDO USA, Inc
- FDA Inspection 1288360 - 2025-09-26
- FDA Inspection 1136893 - 2021-03-03
- FDA Inspection 963017 - 2016-01-27
- FDA Inspection 851401 - 2013-10-28
- FDA Inspection 764681 - 2012-01-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.